Reading the market regime before prices move
Reading the market regime before prices move
Every number here is computed from the traded REGN options chain. The call wall is where dealer hedging accumulates above spot and caps upside, the put wall is its mirror below, and the gamma flip is the level where hedging stops damping moves and starts amplifying them.
Computed
Last completed session, from the Finviro engine close archive · today's session levels refresh every five minutes inside the platform.
Price moves between these levels whether you see them or not. The difference is knowing them before your decision, not after.
You can check SPY, QQQ, NVDA in full right now, with no subscription.
Regeneron Pharmaceuticals, Inc. is a company in the Healthcare sector, listed on the NASDAQ Global Select since 1991, with a market value of about $75.7B. It is led by Leonard S. Schleifer and has about 15,410 employees.
Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses. Its therapeutic portfolio includes EYLEA, an injection used to treat various ophthalmic conditions such as wet age-related macular degeneration, diabetic macular edema, myopic choroidal neovascularization,…
Its beta is 0.24: the stock is usually calmer than the broad market, so its moves are narrower than the index.
On the price was $805.67, above its 50-day simple average (DMA-50 at $790.80) by 1.9%, and above its 200-day average (DMA-200 at $735.62) by 9.5%. Price is above both averages: the medium- and long-term trend is up.
Revenue was $14.34B in fiscal year 2025, against $16.07B in 2021, a change of −11% over 4 years.
Out of every $100 of revenue, about $31 is left as net income after all costs and taxes, so the net margin is 31%.
The operating margin is 25%: what is left of revenue after operating costs, before interest and taxes.
Earnings per share were $43.07 in 2025, against $76.40 in 2021.
Free cash flow was $4.08B: the cash left after spending on operations and investment, which funds dividends and buybacks.
Debt to equity is 0.30: the higher it is, the more the company relies on borrowing.
These numbers describe the company's size and profitability and change slowly, while gamma levels describe how the stock moves within the session.
